Tandem Diabetes Care, Inc. (TNDM)

Market Cap	2.53B
Revenue (ttm)	770.01M
Net Income (ttm)	-141.45M
Shares Out	64.59M
EPS (ttm)	-2.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,257,517
Open	39.65
Previous Close	39.45
Day's Range	38.58 - 39.82
52-Week Range	13.82 - 53.69
Beta	1.27
Analysts	Strong Buy
Price Target	49.54 (+26.54%)
Earnings Date	Aug 1, 2024

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and deliverin...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 14, 2013
• Employees: 2,400
• Stock Exchange: NASDAQ
• Ticker Symbol: TNDM

Financial Performance

In 2023, TNDM's revenue was $747.72 million, a decrease of -6.68% compared to the previous year's $801.22 million. Losses were -$222.61 million, 135.3% more than in 2022.

Analyst Forecast

According to 13 analysts, the average rating for TNDM stock is "Strong Buy." The 12-month stock price forecast is $49.54, which is an increase of 26.54% from the latest price.

Price Target

$49.54

(26.54% upside)

Analyst Consensus: Strong Buy